Compounding Pharmacy · Ocala, FL · Both

Wells Pharmacy Network Review

Wells Pharmacy Network is a compounding pharmacy in Ocala, Florida operating both a 20,500 sq ft 503A pharmacy and a 20,000 sq ft FDA-registered 503B outsourcing facility. Focuses on wellness, weight management, and hormone compounding.

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

BothPCAB
Location: Ocala, FL
Website: wellsrx.com
States licensed: 0
7.9
★★★★☆4/5

Editorial score · methodology

Telehealth Providers Sourcing From This Pharmacy

These telehealth brands are reported to fulfill some or all compounded GLP-1 prescriptions through Wells Pharmacy Network. Sourcing arrangements can change over time.

7.2/ 10
Verified partner

Eden

Best for: mainstream telehealth GLP-1 access

★★★★☆3.6/5

Editorial score · methodology

$138/mosemaglutide
$238/motirzepatide
CompoundedSemaglutideTirzepatideGHK-CuGlutathioneFDA Warning
Get StartedRead full Eden review →

Certifications & Compliance

All sterile compounding pharmacies in the United States are required to follow United States Pharmacopeia General Chapter <797> sterile compounding standards[4], with finished preparations evaluated against USP <71> sterility testing[5] and USP <85> bacterial endotoxin testing[6] as appropriate for the product type.

PCAB
Pharmacy Compounding Accreditation Board — voluntary third-party accreditation (operated by ACHC) auditing the pharmacy against nationally recognized quality and safety standards for sterile and non-sterile compounding.

Drugs Produced

Compounding pharmacies' ability to produce semaglutide or tirzepatide depends on the FDA Drug Shortage List status for each reference product; compounding eligibility can change when a drug moves on or off the shortage list[7].

Semaglutide
Compounded semaglutide produced
Tirzepatide
Compounded tirzepatide produced

States Licensed

Wells Pharmacy Network has not published a state-by-state licensure list. Verify licensure for your state directly with your state board of pharmacy before filling a prescription here.

Regulatory Actions

2014-11-10
FDA Warning Letter issued to Wells Pharmacy Network LLC citing serious deficiencies in sterile drug production practices. Source: Quackwatch archive of FDA letter.
2018-06-22
FDA Form 483 issued to Wells Pharmacy Network LLC, Ocala FL, following inspection. Observations included use of non-pharmaceutical-grade materials in drug preparation. Source: FDA.

External Reviews

Google Reviews
3.7 / 5.0
Based on 65 reviews

Weight Loss Rankings Score Breakdown

Accreditation & Compliance9/10
Regulatory Standing5/10
State Coverage0/10
GLP-1 Production10/10
Track Record5/10

Scores are independently researched. See our methodology for details.

Low confidence · Last verified 2026-04-07 via wave-4-pharmacy-agent · How we verify provider data

Frequently Asked Questions

Wells Pharmacy Network is a Both compounding pharmacy based in Ocala, FL. It holds PCAB accreditation, a voluntary third-party quality standard for compounding pharmacies. Note: our records show 2 documented regulatory action(s) — see the Regulatory Actions section below.
Wells Pharmacy Network is headquartered in Ocala, FL. The pharmacy is licensed to ship to 0 US states.
Wells Pharmacy Network produces compounded semaglutide and compounded tirzepatide in addition to other compounded preparations. As a Both pharmacy, it operates both a patient-specific 503A division and an FDA-registered 503B outsourcing facility.
503A pharmacies prepare compounded medications for individual patients in response to specific prescriptions and are regulated primarily by state boards of pharmacy under USP <797> sterile compounding standards. 503B outsourcing facilities register directly with the FDA, follow current Good Manufacturing Practices (cGMP), and can produce compounded medications in larger batches without patient-specific prescriptions. 503B facilities are subject to FDA inspection.

Key terms, explained

New to GLP-1s? Tap any term for a quick, plain-English definition.

See Top Semaglutide ProvidersAll Pharmacies
Sources & methodology — as of October 2026
  1. 1.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
  2. 2.FDA — 503B Outsourcing Facility Registration and Requirements— U.S. Food & Drug Administration.
  3. 3.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
  4. 4.USP General Chapter <797> — Pharmaceutical Compounding: Sterile Preparations— United States Pharmacopeia.
  5. 5.USP General Chapter <71> — Sterility Tests— United States Pharmacopeia.
  6. 6.USP General Chapter <85> — Bacterial Endotoxins Test— United States Pharmacopeia.
  7. 7.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.